| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |